| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.98B | 55.53B | 57.08B | 55.72B | 53.91B | 55.07B |
| Gross Profit | 16.52B | 15.79B | 15.97B | 15.95B | 15.27B | 17.67B |
| EBITDA | 4.86B | 4.98B | 4.61B | 4.95B | 4.89B | 6.85B |
| Net Income | 1.13B | 1.43B | 951.00M | 1.11B | 1.41B | 2.12B |
Balance Sheet | ||||||
| Total Assets | 78.77B | 80.09B | 80.20B | 81.28B | 79.37B | 80.60B |
| Cash, Cash Equivalents and Short-Term Investments | 10.84B | 10.25B | 11.69B | 11.34B | 13.28B | 12.78B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 10.31B | 10.40B | 11.61B | 12.26B | 10.86B | 10.96B |
| Stockholders Equity | 68.46B | 69.62B | 68.60B | 69.02B | 68.51B | 69.63B |
Cash Flow | ||||||
| Free Cash Flow | 694.00M | -1.06B | 1.37B | 778.00M | 1.92B | 179.00M |
| Operating Cash Flow | 1.46B | 1.65B | 4.49B | 2.80B | 3.33B | 5.10B |
| Investing Cash Flow | -841.50M | -3.78B | -2.82B | -3.42B | -168.00M | -3.33B |
| Financing Cash Flow | -328.00M | -315.00M | -1.31B | -1.31B | -2.67B | -2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥22.54B | 13.97 | ― | 1.87% | 4.26% | 27.55% | |
71 Outperform | ¥4.96T | 31.78 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.38T | 26.50 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥577.98B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
58 Neutral | ¥22.28B | 9.78 | ― | 2.05% | 0.48% | 302.96% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
53 Neutral | ¥44.73B | 262.52 | 1.97% | 2.92% | -2.70% | 50.14% |